Skip to main content
OpenTrials
Completed

NCT Number: NCT01008605

Caverject User Study

The purpose of this study is to demonstrate the usability of the system.

Completed

Looking for future studies?

Notify Me

Key information

Age range

40 year–70 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 3

Primary location

Pfizer Investigational Site, Overland Park, Kansas, United States

Loading trial locations.

About this study

demonstrate usability

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age 40 to 70

Exclusion criteria

Prior syringe skills

Treatment and study plan

delivery system

Other

syringe

Primary outcomes

  1. Percentage of Participants Who Successfully Operated the Caverject Impulse Delivery System

    Time frame: Day 1

    Percentage of participants who were able to successfully expel the selected dose from the Caverject Impulse Delivery System when relying on the modified Instructions for Use. The process was considered successful if the lower bound of the 95% confidence interval (CI) was more than (>) 80% overall.

Secondary outcomes

  1. Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 1

    Time frame: Day 1

    Participant Assessment Tool, Question 1: Instructions provided were useful? Participant responses were reported as follows: Very Useful, Somewhat Useful, Not Very Useful, Not Useful At All.

  2. Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 2

    Time frame: Day 1

    Participant Assessment Tool, Question 2: Instructions provided were clear? Participant responses were reported as follows: Very Clear, Somewhat Clear, Not Very Clear, Not Clear At All.

  3. Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 3

    Time frame: Day 1

    Participant Assessment Tool, Question 3: Most difficult step? Participant responses were reported as follows: No Steps Particularly Difficult, Attaching Needle, Mixing Solution, Getting The Air Out Of Syringe, Dialing Dose, Pushing Plunger, Other.

  4. Number of Participants With Categorical Responses to the Participant Assessment Tool: Question 4

    Time frame: Day 1

    Participant Assessment Tool, Question 4: Syringe easy to use? Participant responses were reported as follows: Very Easy, Somewhat Easy, Somewhat Difficult, Very Difficult

  5. Time Required to Perform Each Step While Using the Caverject Impulse Delivery System

    Time frame: Day 1

    Steps involved while using the Caverject Impulse Delivery System included assembly, mixing the dose, de-aeration, setting the dose, and injecting the dose.

  6. Number of Participants Providing Comments to Any Question on the Participant Assessment Tool

    Time frame: Day 1

    Number of participants providing comments on questions in the Participant Assessment Tool. Questions were as follows: were instructions clear, were instructions useful, which was the most difficult step, and was the syringe easy to use.

Sponsors and collaborators

Lead sponsor

Pfizer

Industry

Registry information

Official study title

Representative Users Study Of Operating Characteristics Of The Caverject Delivery System.

Important dates

Study start
2011
Primary completion
2011
Study completion
2011
First posted
Nov 6, 2009
Registry last updated
Apr 6, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.